ARS Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
20,855
+14,378
| +222% | +$7.55M | 0.8% | 31 |
|
|
2025
Q1 | $4.61M | Sell |
6,477
-3
| -0% | -$2.14K | 0.42% | 46 |
|
|
2024
Q4 | $4.62M | Sell |
6,480
-5,540
| -46% | -$3.95M | 0.42% | 46 |
|
|
2024
Q3 | $12.6M | Buy |
12,020
+142
| +1% | +$149K | 1.13% | 31 |
|
|
2024
Q2 | $12.5M | Sell |
11,878
-128
| -1% | -$135K | 1.19% | 27 |
|
|
2024
Q1 | $11.6M | Buy |
+12,006
| New | +$11.6M | 1.15% | 28 |
|
|
2022
Q4 | – | Sell |
-800
| Closed | -$551K | – | 174 |
|
|
2022
Q3 | $551K | Buy |
+800
| New | +$551K | 0.08% | 97 |
|